What the Nose Shows: Early Determinants of COVID-19 Severity

Researchers at the Ragon Institute and the Broad Institute showed that the early immune response to SARS-CoV-2, found in the nose, may determine the course of the COVID-19 outcome.

T cells Against the Variants

Single-Shot COVID-19 Vaccine Generates Robust Immune Responses Against COVID-19 Variants

New Research Shows Vaccine Protection Against Zika Virus

In a paper published today in the journal Nature, a research team led by scientists at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR) and the University of São Paulo, demonstrates that two different ZIKV vaccine candidates provided complete protection in mice against a ZIKV strain from Brazil and suggest that a ZIKV vaccine for humans will likely be feasible.

Engineered to Fight: Dual CAR T cells show promise against HIV

Researchers from the Ragon Institute of MGH, MIT and Harvard and the Perelman School of Medicine at the University of Pennsylvania developed a new Dual CAR T cell immunotherapy that combats HIV infection in humanized mice.

To B or Not To B: Determining The Fate of a B Cell

An Innately Trained Response Supports Elite Control of HIV

Large collaboration creates cell atlas of COVID-19 pathology